Emergence From the COVID-19 Pandemic and the Care of Chronic Pain: Guidance for the Interventionalist.
Journal
Anesthesia and analgesia
ISSN: 1526-7598
Titre abrégé: Anesth Analg
Pays: United States
ID NLM: 1310650
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
27
5
2020
medline:
23
7
2020
entrez:
27
5
2020
Statut:
ppublish
Résumé
The current coronavirus disease 2019 (COVID-19) pandemic led to a significant disruption in the care of pain from chronic and subacute conditions. The impact of this cessation of pain treatment may have unintended consequences of increased pain, reduced function, increased reliance on opioid medications, and potential increased morbidity, due to the systemic impact of untreated disease burden. This may include decreased mobility, reduction in overall health status, and increase of opioid use with the associated risks. The article is the study of the American Society of Pain and Neuroscience (ASPN) COVID-19 task force to evaluate the policies set forth by federal, state, and local agencies to reduce or eliminate elective procedures for those patients with pain from spine, nerve, and joint disease. The impact of these decisions, which were needed to reduce the spread of the pandemic, led to a delay in care for many patients. We hence review an emergence plan to reinitiate this pain-related care. The goal is to outline a path to work with federal, state, and local authorities to combat the spread of the pandemic and minimize the deleterious impact of pain and suffering on our chronic pain patients. The article sets forth a strategy for the interventional pain centers to reemerge from the current pandemic and to set a course for future events. The COVID-19 pandemic represents an overwhelming challenge to interventional pain physicians and their patients. In addition to urgent actions needed for disease mitigation, the ASPN recommends a staged return to pain management professionals' workflow.
Sections du résumé
BACKGROUND
The current coronavirus disease 2019 (COVID-19) pandemic led to a significant disruption in the care of pain from chronic and subacute conditions. The impact of this cessation of pain treatment may have unintended consequences of increased pain, reduced function, increased reliance on opioid medications, and potential increased morbidity, due to the systemic impact of untreated disease burden. This may include decreased mobility, reduction in overall health status, and increase of opioid use with the associated risks.
METHODS
The article is the study of the American Society of Pain and Neuroscience (ASPN) COVID-19 task force to evaluate the policies set forth by federal, state, and local agencies to reduce or eliminate elective procedures for those patients with pain from spine, nerve, and joint disease. The impact of these decisions, which were needed to reduce the spread of the pandemic, led to a delay in care for many patients. We hence review an emergence plan to reinitiate this pain-related care. The goal is to outline a path to work with federal, state, and local authorities to combat the spread of the pandemic and minimize the deleterious impact of pain and suffering on our chronic pain patients.
RESULTS
The article sets forth a strategy for the interventional pain centers to reemerge from the current pandemic and to set a course for future events.
CONCLUSIONS
The COVID-19 pandemic represents an overwhelming challenge to interventional pain physicians and their patients. In addition to urgent actions needed for disease mitigation, the ASPN recommends a staged return to pain management professionals' workflow.
Identifiants
pubmed: 32452905
doi: 10.1213/ANE.0000000000005000
pmc: PMC7258839
pii: 00000539-202008000-00011
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
387-394Références
Sleep Med Rev. 2006 Oct;10(5):357-69
pubmed: 16386930
N Engl J Med. 2014 Apr 3;370(14):1335-42
pubmed: 24693893
Dis Colon Rectum. 2018 Jan;61(1):77-83
pubmed: 29215474
Anesthesiol Clin. 2016 Jun;34(2):271-85
pubmed: 27208710
Am J Emerg Med. 2014 May;32(5):421-31
pubmed: 24560834
J Occup Environ Hyg. 2014;11(8):D115-28
pubmed: 24628658
Anesth Analg. 2015 Apr;120(4):853-60
pubmed: 25790210
J Clin Oncol. 2002 Oct 1;20(19):4040-9
pubmed: 12351602
Pain Med. 2018 Jun 1;19(6):1293-1294
pubmed: 29415234
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Psychol Med. 2006 May;36(5):575-86
pubmed: 16420727
J Telemed Telecare. 2014 Dec;20(8):427-30
pubmed: 25316038
J Am Coll Surg. 2020 Aug;231(2):281-288
pubmed: 32278725
Mhealth. 2018 May 02;4:11
pubmed: 29963556
J Psychiatr Res. 2012 Jan;46(1):118-27
pubmed: 21944430
Pain Med. 2020 Nov 7;21(7):1331-1346
pubmed: 32259247
Am J Infect Control. 2014 Jul;42(7):698-701
pubmed: 24969122
Ann Oncol. 2005 May;16(5):825-33
pubmed: 15817596
Anaesthesia. 2020 Jul;75(7):935-944
pubmed: 32259288